---
$id: https://graph.org.ai/products/commodity/51172178
$type: Product
source: UNSPSC
code: "51172178"
title: "Pargeverine hydrochloride"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pargeverine hydrochloride

**UNSPSC Code**: 51172178
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C21H23NO3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XT63P694CJ. European Medicines Agency schedules pargeverine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22269. The term pargeverine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule pargeverine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, PARGEVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pargeverine hydrochloride bears US NLM NCI C97987. SMILES: CN(C)CCOC(=O)C(C1CCCCC1)(C2CCCCC2)OCC#C.CL.

